Cargando…

Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak “stable” patients on anti-HBV therapy

Current widely used semiquantitative histological assessment methods are insensitive to identify subtle changes of liver fibrosis. Therefore, to precisely assess therapeutic efficacy on chronic hepatitis B (CHB), we explored the utility of qFibrosis (a fully-quantitative morphometric method employin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yameng, Zhou, Jialing, Wu, Xiaoning, Chen, Yongpeng, Piao, Hongxin, Lu, Lungen, Ding, Huiguo, Nan, Yuemin, Jiang, Wei, Wang, Tailing, Liu, Hui, Ou, Xiaojuan, Wee, Aileen, Theise, Neil D., Jia, Jidong, You, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813020/ https://www.ncbi.nlm.nih.gov/pubmed/29445243 http://dx.doi.org/10.1038/s41598-018-21179-2

Ejemplares similares

An Improved qFibrosis Algorithm for Precise Screening and Enrollment into Non-Alcoholic Steatohepatitis (NASH) Clinical Trials
por: Leow, Wei-Qiang, et al.
Publicado: (2020)

Awaab Ishak and the politics of mould in the UK
por: eClinicalMedicine
Publicado: (2022)

SHG/TPEF-based image technology improves liver fibrosis assessment of minimally sized needle biopsies
por: Wang, Bingqiong, et al.
Publicado: (2019)

Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients
por: Wu, Xiaoning, et al.
Publicado: (2023)

Validation of Ten Noninvasive Diagnostic Models for Prediction of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Cheng, Jieyao, et al.
Publicado: (2015)

Histopathological Study of Chronic Hepatitis B: A Comparative Study of Ishak and METAVIR Scoring Systems
por: Mohamadnejad, M., et al.
Publicado: (2010)

Noninvasive Evaluation of Liver Fibrosis Reverse Using Artificial Neural Network Model for Chronic Hepatitis B Patients
por: Wei, Wei, et al.
Publicado: (2019)

Changing clinical care cascade of patients with chronic hepatitis B in Beijing, China
por: Li, Min, et al.
Publicado: (2021)

Clinical prediction of HBV and HCV related hepatic fibrosis using machine learning
por: Wei, Runmin, et al.
Publicado: (2018)

Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort study
por: Wu, Xiaoning, et al.
Publicado: (2019)

Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis
por: Wang, Mingjie, et al.
Publicado: (2017)

Microcomputed Tomography with Diffraction-Enhanced Imaging for Morphologic Characterization and Quantitative Evaluation of Microvessel of Hepatic Fibrosis in Rats
por: Duan, Jinghao, et al.
Publicado: (2013)

Proteomic and transcriptomic studies of HBV-associated liver fibrosis of an AAV-HBV-infected mouse model
por: Kan, Fangming, et al.
Publicado: (2017)

Updates in the quantitative assessment of liver fibrosis for nonalcoholic fatty liver disease: Histological perspective
por: Soon, Gwyneth, et al.
Publicado: (2021)

Association of Periodontal Diseases and Liver Fibrosis in Patients With HCV and/or HBV infection
por: Nagao, Yumiko, et al.
Publicado: (2014)

Three-dimensional visualization of the microvasculature of bile duct ligation-induced liver fibrosis in rats by x-ray phase-contrast imaging computed tomography
por: Xuan, Ruijiao, et al.
Publicado: (2015)

Relationship of Oxidative Stress in Hepatitis B Infection Activity with HBV DNA and Fibrosis
por: Duygu, Fazilet, et al.
Publicado: (2012)

Concordance between noninvasive assessments of fibrosis in patients with HIV/HIV+HBV infection
por: Dumea, Elena, et al.
Publicado: (2014)

Histopathological Features Predicting Long-term Clinical Outcomes in Patients with Vanishing Bile Duct Syndrome
por: Lv, Tingting, et al.
Publicado: (2023)

Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics
por: Zhang, Bin, et al.
Publicado: (2013)

285. Fibrosis Progression and Clinical Outcomes in HCV/HBV Coinfected Persons in the ERCHIVES Cohort
por: Butt, Adeel A, et al.
Publicado: (2019)

High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis
por: Pu, Xiangke, et al.
Publicado: (2021)

Short hairpin RNA attenuates liver fibrosis by regulating the PPAR-γ and NF-κB pathways in HBV-induced liver fibrosis in mice
por: Ye, Lei, et al.
Publicado: (2020)

Increased Prevalence of Liver Fibrosis and HIV Viremia among Patients with HIV, HBV, and Tuberculosis in Botswana
por: Phinius, Bonolo B., et al.
Publicado: (2020)

Noninvasive Evaluation of Liver Fibrosis in a Sample of Putative Inactive HBV Carriers in Rome, Italy
por: Delle Monache, Marco, et al.
Publicado: (2021)

Arkadia protein expression is reduced in the liver during the progression of hepatic fibrosis
por: Hou, Fei, et al.
Publicado: (2018)

The Diagnostic Accuracy and Clinical Utility of Three Noninvasive Models for Predicting Liver Fibrosis in Patients with HBV Infection
por: Zhang, Zhiqiao, et al.
Publicado: (2016)

Author Correction: High-dimensional hepatopath data analysis by machine learning for predicting HBV-related fibrosis
por: Pu, Xiangke, et al.
Publicado: (2021)

Combination antiretroviral therapy is associated with reduction in liver fibrosis scores in patients with HIV and HBV co-infection
por: Yang, Rongrong, et al.
Publicado: (2021)

Lower prevalence of hepatic fibrosis in low viremic hepatitis B patients with fluctuating HBV DNA levels
por: Sanai, Faisal M., et al.
Publicado: (2022)

Fatty liver is associated with significant liver inflammation and increases the burden of advanced fibrosis in chronic HBV infection
por: Dai, Yi-Ning, et al.
Publicado: (2023)

Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets
por: Li, Hai, et al.
Publicado: (2016)

Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection
por: ZHANG, QINGQING, et al.
Publicado: (2015)

Promotion of liver fibrosis by Y-box binding protein 1 via the attenuation of transforming growth factor-beta 3 transcription
por: Liao, Qiong, et al.
Publicado: (2023)

Is Fibrosis Really Fibrosis?
por: Vijayakumar, Bavithra, et al.
Publicado: (2021)

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022)

Serum Ceruloplasmin Levels Correlate Negatively with Liver Fibrosis in Males with Chronic Hepatitis B: A New Noninvasive Model for Predicting Liver Fibrosis in HBV-Related Liver Disease
por: Zeng, Da-Wu, et al.
Publicado: (2013)

The Diagnosis Value of a Novel Model with 5 Circulating miRNAs for Liver Fibrosis in Patients with Chronic Hepatitis B
por: Zhang, Qingqing, et al.
Publicado: (2021)

Evaluation of adefovir & lamivudine in chronic hepatitis B: Correlation with HBV viral kinetic, hepatic-necro inflammation & fibrosis
por: Pradeep, Kumar S, et al.
Publicado: (2011)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
por: Lu, Xiao-Jie, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ls3g5ncjjsr9cupt2dh1idqme1